Wall Street unfazed by FDA panel’s rejection of company’s wireless heart monitoring device.
|
Medical device maker sees profit, shares dip.
|
Startup InnerPulse grabs the funding from venture capital and med-tech companies for implant to help folks survive sudden cardiac arrest.
|
The med-tech giant’s shares tick upward as defibrillator market stabilizes.
|
Boston Scientific’s CFO stands ground that buying troubled heart device maker Boston Scientific was the best thing the company ever did.
|
Investors look to get insight on the medical device industry’s coming year with top chief Art Collins.
|
Year in Review: Innovation and controversy defined the medical technology industry.
|
If only for a moment, Wall Street thought it knew where to place bets in the fierce competition between the only U.S. heart stent makers.
|
The U.S. federal government starts a two day look into the rising safety concerns surrounding the more than $5 billion drug-coated stent industry.
|
The U.S. government weighs into the heated discussion over safety concerns plaguing the more than $5 billion drug-coated stent industry.
|
Family company digs deep into its pocket to buy next-gen heart tech maker Conor Medsystems.
|
The federal agency publishes plan that could improve post-market device safety.
|
Blood clot risk of drug-coated heart stents versus bare metal ones remains unclear.
|
The med-tech maker finds blood clot risk with its heart stent.
|
Study shows implantable device helps alleviate Parkinson’s symptoms.
|
Medical device maker squirrels away the money to deal with the legal woes of Guidant.
|
Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
|
J&J vows to appeal a judge’s decision that upholds rival company’s heart-device patent.
|
Medical device maker Guidant gets slapped with a lawsuit over its secrecy policy.
|
Recent recalls stir discussion on the reporting and replacement of faulty cardiac devices.
|
Page
1
of
3
|